Tenon Medical, Inc. Operating Expenses
Tenon Medical, Inc. (TNON) reported Operating Expenses of $4.17 million for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-13.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:OperatingExpenses · last filed 2026-08-13
- Tenon Medical, Inc. operating expenses for the quarter ending 2026-06-30 was $4.17M, a 34.36% increase year-over-year.
- Tenon Medical, Inc. operating expenses for the quarter ending 2026-03-31 was $4.22M, a 5.62% increase year-over-year.
- Tenon Medical, Inc. operating expenses for the quarter ending 2025-12-31 was $3.88M, a 10.12% increase year-over-year.
- Tenon Medical, Inc. operating expenses for the quarter ending 2025-09-30 was $4.17M, a 14.64% increase year-over-year.
- Tenon Medical, Inc. operating expenses for fiscal 2025 was $15.15M, a 2.11% decline from fiscal 2024.
- Tenon Medical, Inc. operating expenses for fiscal 2024 was $15.48M, a 8.79% decline from fiscal 2023.
- Tenon Medical, Inc. operating expenses for fiscal 2023 was $16.97M, a 6.17% decline from fiscal 2022.
- Tenon Medical, Inc. operating expenses for fiscal 2022 was $18.08M, a 175.42% increase from fiscal 2021.
| Period end | Operating Expenses 3 month | Operating Expenses 6 month | Operating Expenses 9 month | Operating Expenses 12 month |
|---|---|---|---|---|
| 2026-06-30 | $4.17M 10-Q · filed 2026-08-13 | $8.39M 10-Q · filed 2026-08-13 | $12.28M derived: sum of 3 quarters · filed 2026-08-13 | $16.44M derived: sum of 4 quarters · filed 2026-08-13 |
| 2026-03-31 | $4.22M 10-Q · filed 2026-05-15 | $8.11M derived: sum of 2 quarters · filed 2026-05-15 | $12.27M derived: sum of 3 quarters · filed 2026-05-15 | $15.38M derived: sum of 4 quarters · filed 2026-08-13 |
| 2025-12-31 | $3.88M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-27 | $8.05M derived: sum of 2 quarters · filed 2026-03-27 | $11.15M derived: sum of 3 quarters · filed 2026-08-13 | $15.15M 10-K · filed 2026-03-27 |
| 2025-09-30 | $4.17M 10-Q · filed 2025-11-13 | $7.27M derived: sum of 2 quarters · filed 2026-08-13 | $11.27M 10-Q · filed 2025-11-13 | $14.79M derived: sum of 4 quarters · filed 2026-08-13 |
| 2025-06-30 | $3.10M 10-Q · filed 2026-08-13 | $7.10M 10-Q · filed 2026-08-13 | $10.63M derived: sum of 3 quarters · filed 2026-08-13 | $14.26M derived: sum of 4 quarters · filed 2026-08-13 |
| 2025-03-31 | $4.00M 10-Q · filed 2026-05-15 | $7.53M derived: sum of 2 quarters · filed 2026-05-15 | $11.16M derived: sum of 3 quarters · filed 2026-05-15 | $15.50M derived: sum of 4 quarters · filed 2026-05-15 |
| 2024-12-31 | $3.53M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-27 | $7.16M derived: sum of 2 quarters · filed 2026-03-27 | $11.50M derived: sum of 3 quarters · filed 2026-03-27 | $15.48M 10-K · filed 2026-03-27 |
| 2024-09-30 | $3.63M 10-Q · filed 2025-11-13 | $7.97M derived: sum of 2 quarters · filed 2025-11-13 | $11.95M 10-Q · filed 2025-11-13 | $15.65M derived: sum of 4 quarters · filed 2025-11-13 |
| 2024-06-30 | $4.34M 10-Q · filed 2025-08-13 | $8.32M 10-Q · filed 2025-08-13 | $12.02M derived: sum of 3 quarters · filed 2025-08-13 | $15.93M derived: sum of 4 quarters · filed 2025-08-13 |
| 2024-03-31 | $3.98M 10-Q · filed 2025-05-13 | $7.68M derived: sum of 2 quarters · filed 2025-05-13 | $11.59M derived: sum of 3 quarters · filed 2025-05-13 | $16.11M derived: sum of 4 quarters · filed 2025-05-13 |
| 2023-12-31 | $3.70M derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-26 | $7.61M derived: sum of 2 quarters · filed 2025-03-26 | $12.13M derived: sum of 3 quarters · filed 2025-03-26 | $16.97M 10-K · filed 2025-03-26 |
| 2023-09-30 | $3.91M 10-Q · filed 2024-11-14 | $8.43M derived: sum of 2 quarters · filed 2024-11-14 | $13.27M 10-Q · filed 2024-11-14 | $20.99M derived: sum of 4 quarters · filed 2024-11-14 |
| 2023-06-30 | $4.52M 10-Q · filed 2024-08-13 | $9.36M 10-Q · filed 2024-08-13 | $17.08M derived: sum of 3 quarters · filed 2024-08-13 | $20.24M derived: sum of 4 quarters · filed 2024-08-13 |
| 2023-03-31 | $4.84M 10-Q · filed 2024-05-15 | $12.56M derived: sum of 2 quarters · filed 2024-05-15 | $15.73M derived: sum of 3 quarters · filed 2024-05-15 | $21.05M derived: sum of 4 quarters · filed 2024-05-15 |
| 2022-12-31 | $7.72M derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-29 | $10.89M derived: sum of 2 quarters · filed 2024-03-29 | $16.21M derived: sum of 3 quarters · filed 2024-03-29 | $18.08M 10-K · filed 2024-03-29 |
| 2022-09-30 | $3.17M 10-Q · filed 2023-11-14 | $8.49M derived: sum of 2 quarters · filed 2023-11-14 | $10.36M 10-Q · filed 2023-11-14 | $12.96M derived: sum of 4 quarters · filed 2023-11-14 |
| 2022-06-30 | $5.32M 10-Q · filed 2023-08-11 | $7.20M 10-Q · filed 2023-08-11 | $9.79M derived: sum of 3 quarters · filed 2023-08-11 | $11.94M derived: sum of 4 quarters · filed 2023-08-11 |
| 2022-03-31 | $1.88M 10-Q · filed 2023-05-09 | $4.47M derived: sum of 2 quarters · filed 2023-05-09 | $6.62M derived: sum of 3 quarters · filed 2023-05-09 | $8.25M derived: sum of 4 quarters · filed 2023-05-09 |
| 2021-12-31 | $2.60M derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-10 | $4.75M derived: sum of 2 quarters · filed 2023-03-10 | $6.37M derived: sum of 3 quarters · filed 2023-03-10 | $6.57M 10-K · filed 2023-03-10 |
| 2021-09-30 | $2.15M 10-Q · filed 2022-11-10 | $3.77M derived: sum of 2 quarters · filed 2022-11-10 | $3.97M 10-Q · filed 2022-11-10 | |
| 2021-06-30 | $1.63M 10-Q · filed 2022-08-12 | $1.82M 10-Q · filed 2022-08-12 | ||
| 2021-03-31 | $193.00K 10-Q · filed 2022-06-09 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Profusa, Inc. (PFSA) | United States | $0.002B | |
| Catheter Precision, Inc. (VTAK) | United States | $0.002B | -0.23 |
| INVO Fertility, Inc. (IVF) | United States | $0.002B | -0.71 |
| NEXGEL, INC. (NXGL) | United States | $0.002B | |
| Vivos Therapeutics, Inc. (VVOS) | United States | $0.003B | -0.26 |
| Beyond Air, Inc. (XAIR) | United States | $0.003B | -0.01 |
| Autonomix Medical, Inc. (AMIX) | United States | $0.004B | |
| Adagio Medical Holdings, Inc. (ADGM) | United States | $0.004B | |
| OSR Health, Inc. (OSRH) | United States | $0.004B | -0.75 |
| Bluejay Diagnostics, Inc. (BJDX) | United States | $0.004B |